Welcome to LookChem.com Sign In|Join Free
  • or
1H-1,2,4-Triazole, 1-(4-hydrazinophenyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

152537-06-9

Post Buying Request

152537-06-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

152537-06-9 Usage

Chemical Structure

1H-1,2,4-Triazole derivative with a hydrazine functional group attached to a phenyl ring

Explanation

The chemical structure describes the arrangement of atoms and the type of chemical bonds between them. 1H-1,2,4-Triazole, 1-(4-hydrazinophenyl)- is a derivative of 1H-1,2,4-triazole, which has a hydrazine group (NH-NH2) attached to a phenyl ring (C6H5).

Explanation

Due to its versatile chemical structure, 1H-1,2,4-Triazole, 1-(4-hydrazinophenyl)- is used as a starting material for the synthesis of various drugs and chemicals used in agriculture.

Explanation

The compound exhibits a range of biological activities, which means it can potentially be used to combat fungal, bacterial infections, and even cancer.

Explanation

As a ligand, 1H-1,2,4-Triazole, 1-(4-hydrazinophenyl)- can form complexes with metal ions, which can be useful in various chemical reactions and applications.

Explanation

The compound can help stabilize metal ions in water, which is important for maintaining the stability and reactivity of metal-containing compounds.

Explanation

Due to its various properties and applications, 1H-1,2,4-Triazole, 1-(4-hydrazinophenyl)is considered a versatile compound with significant relevance in both the medical and chemical fields.

Applications

Building block in the synthesis of pharmaceuticals and agrochemicals

Biological Activities

Antifungal, antibacterial, and anticancer properties

Use as a Ligand

In coordination chemistry

Stabilizer

For metal ions in aqueous solutions

Versatility

Important applications in medicine and chemistry

Check Digit Verification of cas no

The CAS Registry Mumber 152537-06-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,5,3 and 7 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 152537-06:
(8*1)+(7*5)+(6*2)+(5*5)+(4*3)+(3*7)+(2*0)+(1*6)=119
119 % 10 = 9
So 152537-06-9 is a valid CAS Registry Number.

152537-06-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(1,2,4-triazol-1-yl)-phenylhydrazine

1.2 Other means of identification

Product number -
Other names 4-(1,2,4-triazol-1-yl)phenylhydrazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:152537-06-9 SDS

152537-06-9Downstream Products

152537-06-9Relevant academic research and scientific papers

3-[3-(piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists

Russell, Michael G. N.,Matassa, Victor G.,Pengilley, Roy R.,Van Niel, Monique B.,Sohal, Bindi,Watt, Alan P.,Hitzel, Laure,Beer, Margaret S.,Stanton, Josephine A.,Broughton, Howard B.,Castro, José L.

, p. 4981 - 5001 (2007/10/03)

Several 5-HT(ID/1B) receptor agonists are now entering the marketplace as treatments for migraine. This paper describes the development of selective h5-HT(1D)receptor agonists as potential antimigraine agents which may produce fewer side effects. A series of 3-[3-(piperidin-1-yl)propyl]indoles has been synthesized which has led to the identification of 80 (L-772,405), a high- affinity h5-HT(1D) receptor full agonist having 170-fold selectivity for h5- HT(1D) receptors over h5-HT(1B) receptors. L-772,405 also shows very good selectivity over a range of other serotonin and nonserotonin receptors and has excellent bioavailability following subcutaneous administration in rats. It therefore constitutes a valuable tool to delineate the role of h5-HT(1D) receptors in migraine. Molecular modeling and physical properties have been utilized to postulate the binding conformation of these compounds in the receptor cavity.

Imidazole, triazole and tetrazole derivatives

-

, (2008/06/13)

A class of substituted imidazole, triazole and tetrazole derivatives of formula (I), wherein the broken circle represents two non-adjacent double bonds in any position in the five-membered ring; two, three or four of V,W,X,Y and Z represent nitrogen and the remainder represent carbon provided that, when two of V,W,X,Y and Z represent nitrogen and the remainder represent carbon, then the said nitrogen atoms are in non-adjacent positions within the five-membered ring; E represents a bond or a straight or branched alkylene chain containing from 1 to 4 carbon atoms; F represents a group of formula (lI); U represents nitrogen or C--R2 ; B represents oxygen, sulphur or N--R3 ; are selective agonists of 5--HT1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated.

Imidazole, Triazole and tetrazole derivatives

-

, (2008/06/13)

Imidazole, triazole and tetrazole derivatives of formula (I) are selective agonists of 5-HT1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated, wherein the broken circle represents two non-adjacent double bonds in any position in the five-membered ring; two, three or four of V, W, X, Y and Z represent nitrogen and the remainder represent carbon provided that, when two of V, W, X, Y and Z represent nitrogen and the remainder represent carbon, then the said nitrogen atoms are in non-adjacent positions within the five-membered ring; E represents a bond or a straight or branched alkylene chain containing from 1 to 4 carbon atoms; F represents a group of formula (a); U represents nitrogen or C--R2 ; B represents oxygen, sulphur or N--R3 ; R1 represents a group of formula (i), (ii) or (iii).

Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol- 1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: Potent agonists for 5- HT(1D) receptors

Street,Baker,Davey,Guiblin,Jelley,Reeve,Routledge,Sternfeld,Watt,Beer,Middlemiss,Noble,Stanton,Scholey,Hargreaves,Sohal,Graham,Matassa

, p. 1799 - 1810 (2007/10/02)

The synthesis and the 5-HT receptor activity of a novel series of N,N- dimethyltryptamines substituted in the 5-position with an imidazole, triazole, or tetrazole ring are described. The objective of this work was to identify potent and selective 5-HT(1D) receptor agonists with high oral bioavailability and low central nervous system penetration. Compounds have been prepared in which the azole ring is attached through either nitrogen or carbon to the indole. Conjugated and methylene-bridged derivatives have been studied (n = 0 or 1). Substitution of the azole ring has been explored either α or β to the point of attachment to indole. In a series of N-linked azoles (X = N), simple unsubstituted compounds have high affinity and selectivity for 5-HT(1D) receptors. It is proposed that for good affinity and selectivity a hydrogen bond acceptor interaction with the 5-HT(1D) receptor, through a β-nitrogen in the azole ring, is required. In a series of C-linked triazoles and tetrazoles (X = C), optimal affinity and selectivity for the 5-HT(1D) receptor was observed when the azole ring is substituted at the 1-position with a methyl or ethyl group. This study has led to the discovery of the 1,2,4-triazole 10a (MK-462) as a potent and selective 5-HT(1D) receptor agonist which has high oral bioavailability and rapid oral absorption. The in vitro activity and the preliminary pharmacokinetics of compounds in this series are presented.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 152537-06-9